News for Global Health Limited (GLH.AX)

TORONTO, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Blue Moon Metals Inc. (”œBlue Moon”) (TSXV: MOON), Nussir ASA (”œNussir”) and Nye Sulitjelma Gruver AS (”œNS

**media[550524]**

Australian X-ray technology company Micro-X will develop a world-first full-body mobile CT following the award of an up to US$16.4m (A$25m) development contrac

**media[521488]**

Which sector of the ASX is flying under the radar, yet may be full of potential? If you said Healthcare, you’re on the right track.

Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.

SYDNEY, Sept. 26, 2024 /PRNewswire/ -- Cardiex Limited (ASX: CDX), a global health technology company focused on cardiovascular diagnostics and arterial health solutions, today announced the publication of a peer-reviewed study validating its innovative method for measuring central aortic pressure-an important indicator of heart health-using a noninvasive fingertip sensor. The study, co-authored by Cardiex's team, was published in the respected journal Pulse.

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

Aussie markets have somehow pulled of a miracle gain despite two horror sessions this week.

Recce Pharmaceuticals Reports Positive Preclinical Data of RECCE ® 327 in Lung Infection Pilot Study

Certain Equity Shares of Global Health Limited are subject to a Lock-Up Agreement Ending on 13-MAY-2024. These Equity Shares will be under lockup for 551 days starting from 9-NOV-2022 to...

Telix Pharmaceuticals Limited completes the acquisition of AR™S, Inc.

Recce Pharmaceuticals Selected by UK Government Innovation Agency to Participate in AMR Mission 2024

In this article, we will be taking a look at the 20 biggest health care companies in Australia, 2024.

Nifty futures on the NSE International Exchange traded 4 points, or 0.02 per cent, lower at 22,051, hinting at a flattish start for the domestic market on Thursday.

Dayforce® recurring revenue of $292.1 million, up 30.1% year-over-year in the fourth quarter, or 29.9% on a constant currency basis Total revenue of...

The ASX200 finished off the first day of December down 0.2 of a percent - with all sectors, except energy, losing some ground.

Lawyers for descendants of the late Peter Wright were first on the stand today, taking on Gina Rinehart over ownership and royalties relating to Hope Downs iron ore operations in the Pilbara.

The ASX levelled out as the market digested news there will be a new RBA Governor. With Phillip Lowe out and Michelle Bullock in